Production (Stage)
Universal Ibogaine Inc.
IBO.V
TSX
| 04/30/2025 | 01/31/2025 | ||||
|---|---|---|---|---|---|
| Revenue | 88.60% | -16.80% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 88.60% | -16.80% | |||
| Cost of Revenue | 23.88% | -21.93% | |||
| Gross Profit | 2,113.58% | 177.88% | |||
| SG&A Expenses | 4.57% | -5.96% | |||
| Depreciation & Amortization | -9.73% | 6.45% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 16.29% | -18.10% | |||
| Operating Income | 89.18% | 19.92% | |||
| Income Before Tax | 78.24% | 15.64% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 78.24% | 15.64% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 78.24% | 15.64% | |||
| EBIT | 89.18% | 19.92% | |||
| EBITDA | 131.90% | 29.33% | |||
| EPS Basic | 71.43% | 12.50% | |||
| Normalized Basic EPS | 75.00% | 20.00% | |||
| EPS Diluted | 71.43% | 12.50% | |||
| Normalized Diluted EPS | 75.00% | 20.00% | |||
| Average Basic Shares Outstanding | 0.00% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.00% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||